MR编号 | NL/H/4533/001 |
---|
药品名称 | Gaviscon Double Action Liquid |
---|
活性成分 | - Calcium carbonate 500.0 mg/g
- Sodium bicarbonate 500.0 mg/g
- Sodium chloride 500.0 mg/g
|
---|
剂型 | Oral suspension |
---|
上市许可持有人 | Reckitt Benckiser Healthcare (UK) Limited
Dansom Lane
Hull
HU8 7DS
United Kingdom |
---|
参考成员国 - 产品名称 | Netherlands (NL) Gaviscon Duo suspensie, suspensie voor oraal gebruik |
---|
互认成员国 - 产品名称 | - Germany (DE)
Gaviscon Double Action 500 mg/213 mg/325 mg Suspension zum Einnehmen - Belgium (BE)
- Luxembourg (LU)
- Ireland (IE)
- Greece (GR)
- Cyprus (CY)
GAVISCON DOUBLE ACTION LIQUID - Czechia (CZ)
Gaviscon Double Action Liquid - Slovakia (SK)
Gaviscon Double Action
|
---|
许可日期 | 2010/05/18 |
---|
最近更新日期 | 2025/02/03 |
---|
药物ATC编码 | - A02BX Other drugs for peptic ulcer and gastro-oesophageal reflux disease (GORD)
|
---|
申请类型 | - TypeLevel1:[not specified]
- TypeLevel2:[not specified]
- TypeLevel3:[not specified]
- TypeLevel4:[not specified]
- TypeLevel5:[not specified]
|
---|
附件文件下载 | |
---|
市场状态 | Positive |
---|